Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity

Descripción del Articulo

Mycobacterium tuberculosis nicotinamidase-pyrazinamidase (PZAse) is a metalloenzyme that catalyzes conversion of nicotinamide-pyrazinamide to nicotinic acid-pyrazinoic acid. This study investigated whether a metallochaperone is required for optimal PZAse activity. M. tuberculosis and Escherichia col...

Descripción completa

Detalles Bibliográficos
Autores: Sheen P., Monsalve A., Campos J., Huerta R., Antiparra R., Arteaga H., Duran P., Bueno C., Kirwan D.E., Gilman R.H., Zimic M.
Formato: artículo
Fecha de Publicación:2020
Institución:Consejo Nacional de Ciencia Tecnología e Innovación
Repositorio:CONCYTEC-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.concytec.gob.pe:20.500.12390/2651
Enlace del recurso:https://hdl.handle.net/20.500.12390/2651
https://doi.org/10.1128/JB.00331-19
Nivel de acceso:acceso abierto
Materia:ZnuA
Mechanism of action
Mechanism of resistance
Metal depletion
Metallochaperone
Metalloenzyme
Mycobacterium tuberculosis
Pyrazinamide
Pyrazinoic acid
PZA resistance
Reactivation
Resistance
Rv2059
http://purl.org/pe-repo/ocde/ford#3.03.08
id CONC_a4d69e7f68419f25364a5f1d0d098a43
oai_identifier_str oai:repositorio.concytec.gob.pe:20.500.12390/2651
network_acronym_str CONC
network_name_str CONCYTEC-Institucional
repository_id_str 4689
dc.title.none.fl_str_mv Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity
title Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity
spellingShingle Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity
Sheen P.
ZnuA
Mechanism of action
Mechanism of resistance
Metal depletion
Metallochaperone
Metalloenzyme
Mycobacterium tuberculosis
Pyrazinamide
Pyrazinoic acid
PZA resistance
Reactivation
Resistance
Rv2059
http://purl.org/pe-repo/ocde/ford#3.03.08
title_short Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity
title_full Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity
title_fullStr Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity
title_full_unstemmed Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity
title_sort Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity
author Sheen P.
author_facet Sheen P.
Monsalve A.
Campos J.
Huerta R.
Antiparra R.
Arteaga H.
Duran P.
Bueno C.
Kirwan D.E.
Gilman R.H.
Zimic M.
author_role author
author2 Monsalve A.
Campos J.
Huerta R.
Antiparra R.
Arteaga H.
Duran P.
Bueno C.
Kirwan D.E.
Gilman R.H.
Zimic M.
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sheen P.
Monsalve A.
Campos J.
Huerta R.
Antiparra R.
Arteaga H.
Duran P.
Bueno C.
Kirwan D.E.
Gilman R.H.
Zimic M.
dc.subject.none.fl_str_mv ZnuA
topic ZnuA
Mechanism of action
Mechanism of resistance
Metal depletion
Metallochaperone
Metalloenzyme
Mycobacterium tuberculosis
Pyrazinamide
Pyrazinoic acid
PZA resistance
Reactivation
Resistance
Rv2059
http://purl.org/pe-repo/ocde/ford#3.03.08
dc.subject.es_PE.fl_str_mv Mechanism of action
Mechanism of resistance
Metal depletion
Metallochaperone
Metalloenzyme
Mycobacterium tuberculosis
Pyrazinamide
Pyrazinoic acid
PZA resistance
Reactivation
Resistance
Rv2059
dc.subject.ocde.none.fl_str_mv http://purl.org/pe-repo/ocde/ford#3.03.08
description Mycobacterium tuberculosis nicotinamidase-pyrazinamidase (PZAse) is a metalloenzyme that catalyzes conversion of nicotinamide-pyrazinamide to nicotinic acid-pyrazinoic acid. This study investigated whether a metallochaperone is required for optimal PZAse activity. M. tuberculosis and Escherichia coli PZAses (PZAse-MT and PZAse-EC, respectively) were inactivated by metal depletion (giving PZAse-MT–Apo and PZAse-EC–Apo). Reactivation with the E. coli metallochaperone ZnuA or Rv2059 (the M. tuberculosis analog) was measured. This was repeated following proteolytic and thermal treatment of ZnuA and Rv2059. The CDC1551 M. tuberculosis reference strain had the Rv2059 coding gene knocked out, and PZA susceptibility and the pyrazinoic acid (POA) efflux rate were measured. ZnuA (200 M) achieved 65% PZAse-EC–Apo reactivation. Rv2059 (1 M) and ZnuA (1 M) achieved 69% and 34.3% PZAse-MT–Apo reactivation, respectively. Proteolytic treatment of ZnuA and Rv2059 and application of three (but not one) thermal shocks to ZnuA significantly reduced the capacity to reactivate PZAse-MT–Apo. An M. tuberculosis Rv2059 knockout strain was Wayne positive and susceptible to PZA and did not have a significantly different POA efflux rate than the reference strain, although a trend toward a lower efflux rate was observed after knockout. The metallochaperone Rv2059 restored the activity of metal-depleted PZAse in vitro. Although Rv2059 is important in vitro, it seems to have a smaller effect on PZA susceptibility in vivo. It may be important to mechanisms of action and resistance to pyrazinamide in M. tuberculosis. Further studies are needed for confirmation. IMPORTANCE Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis and remains one of the major causes of disease and death worldwide. Pyrazinamide is a key drug used in the treatment of tuberculosis, yet its mechanism of action is not fully understood, and testing strains of M. tuberculosis for pyrazinamide resistance is not easy with the tools that are presently available. The significance of the present research is that a metallochaperone-like protein may be crucial to pyrazinamide’s mechanisms of action and of resistance. This may support the development of improved tools to detect pyrazinamide resistance, which would have significant implications for the clinical management of patients with tuberculosis: drug regimens that are appropriately tailored to the resistance profile of a patient’s individual strain lead to better clinical outcomes, reduced onward transmission of infection, and reduction of the development of resistant strains that are more challenging and expensive to treat. Copyright © 2020 Sheen et al.
publishDate 2020
dc.date.accessioned.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.available.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.issued.fl_str_mv 2020
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12390/2651
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1128/JB.00331-19
dc.identifier.scopus.none.fl_str_mv 2-s2.0-85077475190
url https://hdl.handle.net/20.500.12390/2651
https://doi.org/10.1128/JB.00331-19
identifier_str_mv 2-s2.0-85077475190
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Journal of Bacteriology
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
dc.publisher.none.fl_str_mv American Society for Microbiology
publisher.none.fl_str_mv American Society for Microbiology
dc.source.none.fl_str_mv reponame:CONCYTEC-Institucional
instname:Consejo Nacional de Ciencia Tecnología e Innovación
instacron:CONCYTEC
instname_str Consejo Nacional de Ciencia Tecnología e Innovación
instacron_str CONCYTEC
institution CONCYTEC
reponame_str CONCYTEC-Institucional
collection CONCYTEC-Institucional
bitstream.url.fl_str_mv https://repositorio.concytec.gob.pe/bitstreams/3df4eede-8f12-4463-b559-722063cade67/download
https://repositorio.concytec.gob.pe/bitstreams/ef55fc7c-9f5f-40d1-ad80-a5f50d3932f2/download
https://repositorio.concytec.gob.pe/bitstreams/f7cbb341-76ed-4a44-84ca-040bb176affd/download
bitstream.checksum.fl_str_mv 54bdfad67e52703f12134d616c848ac3
7bb1c8ce008c25db5edfacc65a760fe4
f08fe950e375a3b4224a1f81d1b022f4
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional CONCYTEC
repository.mail.fl_str_mv repositorio@concytec.gob.pe
_version_ 1839175760833675264
spelling Publicationrp00526600rp06845600rp06843600rp06846600rp00913600rp02304600rp06842600rp06844600rp06568600rp00604600rp00606600Sheen P.Monsalve A.Campos J.Huerta R.Antiparra R.Arteaga H.Duran P.Bueno C.Kirwan D.E.Gilman R.H.Zimic M.2024-05-30T23:13:38Z2024-05-30T23:13:38Z2020https://hdl.handle.net/20.500.12390/2651https://doi.org/10.1128/JB.00331-192-s2.0-85077475190Mycobacterium tuberculosis nicotinamidase-pyrazinamidase (PZAse) is a metalloenzyme that catalyzes conversion of nicotinamide-pyrazinamide to nicotinic acid-pyrazinoic acid. This study investigated whether a metallochaperone is required for optimal PZAse activity. M. tuberculosis and Escherichia coli PZAses (PZAse-MT and PZAse-EC, respectively) were inactivated by metal depletion (giving PZAse-MT–Apo and PZAse-EC–Apo). Reactivation with the E. coli metallochaperone ZnuA or Rv2059 (the M. tuberculosis analog) was measured. This was repeated following proteolytic and thermal treatment of ZnuA and Rv2059. The CDC1551 M. tuberculosis reference strain had the Rv2059 coding gene knocked out, and PZA susceptibility and the pyrazinoic acid (POA) efflux rate were measured. ZnuA (200 M) achieved 65% PZAse-EC–Apo reactivation. Rv2059 (1 M) and ZnuA (1 M) achieved 69% and 34.3% PZAse-MT–Apo reactivation, respectively. Proteolytic treatment of ZnuA and Rv2059 and application of three (but not one) thermal shocks to ZnuA significantly reduced the capacity to reactivate PZAse-MT–Apo. An M. tuberculosis Rv2059 knockout strain was Wayne positive and susceptible to PZA and did not have a significantly different POA efflux rate than the reference strain, although a trend toward a lower efflux rate was observed after knockout. The metallochaperone Rv2059 restored the activity of metal-depleted PZAse in vitro. Although Rv2059 is important in vitro, it seems to have a smaller effect on PZA susceptibility in vivo. It may be important to mechanisms of action and resistance to pyrazinamide in M. tuberculosis. Further studies are needed for confirmation. IMPORTANCE Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis and remains one of the major causes of disease and death worldwide. Pyrazinamide is a key drug used in the treatment of tuberculosis, yet its mechanism of action is not fully understood, and testing strains of M. tuberculosis for pyrazinamide resistance is not easy with the tools that are presently available. The significance of the present research is that a metallochaperone-like protein may be crucial to pyrazinamide’s mechanisms of action and of resistance. This may support the development of improved tools to detect pyrazinamide resistance, which would have significant implications for the clinical management of patients with tuberculosis: drug regimens that are appropriately tailored to the resistance profile of a patient’s individual strain lead to better clinical outcomes, reduced onward transmission of infection, and reduction of the development of resistant strains that are more challenging and expensive to treat. Copyright © 2020 Sheen et al.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - ConcytecengAmerican Society for MicrobiologyJournal of Bacteriologyinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/ZnuAMechanism of action-1Mechanism of resistance-1Metal depletion-1Metallochaperone-1Metalloenzyme-1Mycobacterium tuberculosis-1Pyrazinamide-1Pyrazinoic acid-1PZA resistance-1Reactivation-1Resistance-1Rv2059-1http://purl.org/pe-repo/ocde/ford#3.03.08-1Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activityinfo:eu-repo/semantics/articlereponame:CONCYTEC-Institucionalinstname:Consejo Nacional de Ciencia Tecnología e Innovacióninstacron:CONCYTEC#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#ORIGINALMetallochaperones Are Needed for Mycobacterium tuberculosis.pdfMetallochaperones Are Needed for Mycobacterium tuberculosis.pdfapplication/pdf2119044https://repositorio.concytec.gob.pe/bitstreams/3df4eede-8f12-4463-b559-722063cade67/download54bdfad67e52703f12134d616c848ac3MD51TEXTMetallochaperones Are Needed for Mycobacterium tuberculosis.pdf.txtMetallochaperones Are Needed for Mycobacterium tuberculosis.pdf.txtExtracted texttext/plain66472https://repositorio.concytec.gob.pe/bitstreams/ef55fc7c-9f5f-40d1-ad80-a5f50d3932f2/download7bb1c8ce008c25db5edfacc65a760fe4MD52THUMBNAILMetallochaperones Are Needed for Mycobacterium tuberculosis.pdf.jpgMetallochaperones Are Needed for Mycobacterium tuberculosis.pdf.jpgGenerated Thumbnailimage/jpeg5647https://repositorio.concytec.gob.pe/bitstreams/f7cbb341-76ed-4a44-84ca-040bb176affd/downloadf08fe950e375a3b4224a1f81d1b022f4MD5320.500.12390/2651oai:repositorio.concytec.gob.pe:20.500.12390/26512025-01-18 22:00:33.614https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessopen accesshttps://repositorio.concytec.gob.peRepositorio Institucional CONCYTECrepositorio@concytec.gob.pe#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="d137f387-1373-4d4d-9ae9-d57f73d88610"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity</Title> <PublishedIn> <Publication> <Title>Journal of Bacteriology</Title> </Publication> </PublishedIn> <PublicationDate>2020</PublicationDate> <DOI>https://doi.org/10.1128/JB.00331-19</DOI> <SCP-Number>2-s2.0-85077475190</SCP-Number> <Authors> <Author> <DisplayName>Sheen P.</DisplayName> <Person id="rp00526" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Monsalve A.</DisplayName> <Person id="rp06845" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Campos J.</DisplayName> <Person id="rp06843" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Huerta R.</DisplayName> <Person id="rp06846" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Antiparra R.</DisplayName> <Person id="rp00913" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Arteaga H.</DisplayName> <Person id="rp02304" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Duran P.</DisplayName> <Person id="rp06842" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Bueno C.</DisplayName> <Person id="rp06844" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Kirwan D.E.</DisplayName> <Person id="rp06568" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Gilman R.H.</DisplayName> <Person id="rp00604" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Zimic M.</DisplayName> <Person id="rp00606" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>American Society for Microbiology</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by/4.0/</License> <Keyword>ZnuA</Keyword> <Keyword>Mechanism of action</Keyword> <Keyword>Mechanism of resistance</Keyword> <Keyword>Metal depletion</Keyword> <Keyword>Metallochaperone</Keyword> <Keyword>Metalloenzyme</Keyword> <Keyword>Mycobacterium tuberculosis</Keyword> <Keyword>Pyrazinamide</Keyword> <Keyword>Pyrazinoic acid</Keyword> <Keyword>PZA resistance</Keyword> <Keyword>Reactivation</Keyword> <Keyword>Resistance</Keyword> <Keyword>Rv2059</Keyword> <Abstract>Mycobacterium tuberculosis nicotinamidase-pyrazinamidase (PZAse) is a metalloenzyme that catalyzes conversion of nicotinamide-pyrazinamide to nicotinic acid-pyrazinoic acid. This study investigated whether a metallochaperone is required for optimal PZAse activity. M. tuberculosis and Escherichia coli PZAses (PZAse-MT and PZAse-EC, respectively) were inactivated by metal depletion (giving PZAse-MT–Apo and PZAse-EC–Apo). Reactivation with the E. coli metallochaperone ZnuA or Rv2059 (the M. tuberculosis analog) was measured. This was repeated following proteolytic and thermal treatment of ZnuA and Rv2059. The CDC1551 M. tuberculosis reference strain had the Rv2059 coding gene knocked out, and PZA susceptibility and the pyrazinoic acid (POA) efflux rate were measured. ZnuA (200 M) achieved 65% PZAse-EC–Apo reactivation. Rv2059 (1 M) and ZnuA (1 M) achieved 69% and 34.3% PZAse-MT–Apo reactivation, respectively. Proteolytic treatment of ZnuA and Rv2059 and application of three (but not one) thermal shocks to ZnuA significantly reduced the capacity to reactivate PZAse-MT–Apo. An M. tuberculosis Rv2059 knockout strain was Wayne positive and susceptible to PZA and did not have a significantly different POA efflux rate than the reference strain, although a trend toward a lower efflux rate was observed after knockout. The metallochaperone Rv2059 restored the activity of metal-depleted PZAse in vitro. Although Rv2059 is important in vitro, it seems to have a smaller effect on PZA susceptibility in vivo. It may be important to mechanisms of action and resistance to pyrazinamide in M. tuberculosis. Further studies are needed for confirmation. IMPORTANCE Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis and remains one of the major causes of disease and death worldwide. Pyrazinamide is a key drug used in the treatment of tuberculosis, yet its mechanism of action is not fully understood, and testing strains of M. tuberculosis for pyrazinamide resistance is not easy with the tools that are presently available. The significance of the present research is that a metallochaperone-like protein may be crucial to pyrazinamide’s mechanisms of action and of resistance. This may support the development of improved tools to detect pyrazinamide resistance, which would have significant implications for the clinical management of patients with tuberculosis: drug regimens that are appropriately tailored to the resistance profile of a patient’s individual strain lead to better clinical outcomes, reduced onward transmission of infection, and reduction of the development of resistant strains that are more challenging and expensive to treat. Copyright © 2020 Sheen et al.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication> -1
score 13.210282
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).